Kinase inhibitors attract attention as oral rheumatoid arthritis drugs

Nat Rev Drug Discov. 2010 Apr;9(4):257-8. doi: 10.1038/nrd3155.
No abstract available

MeSH terms

  • Administration, Oral
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / physiopathology
  • Clinical Trials as Topic
  • Drug Delivery Systems*
  • Drug Design
  • Humans
  • Oxazines / pharmacology
  • Oxazines / therapeutic use
  • Piperidines
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyridines / pharmacology
  • Pyridines / therapeutic use
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use

Substances

  • Oxazines
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyridines
  • Pyrimidines
  • Pyrroles
  • tofacitinib
  • fostamatinib